[1]
Chauhan, A.S., Thakur, M., Meena, K.L. and Yadav, K. 2022. Efficacy of sofosbuvir and daclatasvir in compensated chronic hepatitis C infection: A single center, open-label and proof of concept study. International journal of health sciences. 6, S5 (Aug. 2022), 7984–7996. DOI:https://doi.org/10.53730/ijhs.v6nS5.10510.